Jinarc 30 mg tablets + Jinarc 90 mg tablets

DRUG2 trials

Sponsors

University Medical Center Groningen, University Of Bari Aldo Moro

Conditions

Autosomal Dominant Polycystic Kidney DiseaseAutosomal Dominant Polycystic Kidney Disease (ADPKD)

Phase 3

HYDROchlorothiazide to PROTECT polycystic kidney disease patients and improve their quality of life (HYDRO-PROTECT)

RecruitingCTIS2022-500210-26-00

University Medical Center GroningenAutosomal Dominant Polycystic Kidney Disease (ADPKD)

Start: 2024-06-28Target: 260Updated: 2025-11-05

Metformin versus Tolvaptan in adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD): a phase 3a, independent, multi- centre, 2 parallel arms randomized controlled trial

RecruitingCTIS2024-517864-49-01

University Of Bari Aldo MoroAutosomal Dominant Polycystic Kidney Disease

Start: 2020-09-08Target: 150Updated: 2025-09-12